0 20

Cited 0 times in

Cited 0 times in

A Response to the Letter to the Editor: "Durable Benefit Beyond Response: Reinterpreting Amivantamab Efficacy in METex14 NSCLC Subgroups

Authors
 Krebs, Matthew G.  ;  Cho, Byoung Chul  ;  Kim, Priya  ;  Spira, Alexander I.  ;  Leighl, Natasha B. 
Citation
 JOURNAL OF THORACIC ONCOLOGY, Vol.20(10) : e109-e110, 2025-10 
Journal Title
JOURNAL OF THORACIC ONCOLOGY
ISSN
 1556-0864 
Issue Date
2025-10
Full Text
https://www.sciencedirect.com/science/article/pii/S1556086425008251
DOI
10.1016/j.jtho.2025.07.003
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Cho, Byoung Chul(조병철) ORCID logo https://orcid.org/0000-0002-5562-270X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/209822
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links